BLTE – belite bio, inc - american depositary shares (US:NASDAQ)
Stock Stats
News
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $57.00 price target on the stock.
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $59.00 price target on the stock.
Belite Bio, Inc (NASDAQ: BLTE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Form 144 BELITE BIO, INC Filed by: MATA NATHAN L.
Form 144 BELITE BIO, INC Filed by: Chiu Ching Chen
Form 6-K BELITE BIO, INC For: May 13
Form 424B5 BELITE BIO, INC
Form 6-K BELITE BIO, INC For: Apr 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.